How does UNITED THERAPEUTICS CORP (NASDAQ:UTHR) stack up against Peter Lynch’s investment principles?

Peter Lynch was known for finding hidden gems in the market before they became mainstream. Is UNITED THERAPEUTICS CORP (NASDAQ:UTHR) one of those under-the-radar stocks that fits his legendary strategy?

Following Peter Lynch’s approach: Does UNITED THERAPEUTICS CORP (NASDAQ:UTHR) fit the bill?

• UTHR showcases a robust Return on Equity (ROE) of 18.55%, indicating its ability to generate favorable returns for shareholders. This metric underscores the company's efficiency in utilizing its equity capital to generate profits.
• A Debt/Equity ratio of 0.0 indicates that UTHR is leveraging debt effectively without excessive risk.
• The EPS of UTHR has shown consistent growth over a 5-year period, indicating the company's ability to generate increasing earnings over time.
• UTHR boasts a PEG ratio of 0.67, indicating a reasonable valuation relative to its earnings growth.
• UTHR's Current Ratio of 5.25 reflects a strong ability to manage short-term financial commitments.

A complete fundamental analysis of UTHR

Every day ChartMill assigns a Fundamental Rating to every stock. The score ranges from 0 to 10 and is determined by evaluating multiple fundamental indicators and properties.

Overall UTHR gets a fundamental rating of 7 out of 10. We evaluated UTHR against 567 industry peers in the Biotechnology industry. UTHR gets an excellent profitability rating and is at the same time showing great financial health properties. A decent growth rate in combination with a cheap valuation! Better keep an eye on UTHR. With these ratings, UTHR could be worth investigating further for value and quality investing!.

Check the latest full fundamental report of UTHR for a complete fundamental analysis.

Every day, new Affordable Growth stocks can be found on ChartMill in our Peter Lynch screener.

Disclaimer

This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.